Lensar LNSR
NASDAQ LNSR
$6.75 +0.18 (+2.74%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lensar (LNSR) Asset Writedowns and Impairment (2021 - 2024)

Updated

Lensar's Asset Writedowns and Impairment came in at $3.73 million for FY2024, compared with $66,000 in FY2023.

Analysis

Lensar (LNSR) Asset Writedowns and Impairment (2021 - 2024) Analysis & Trends

Going back to FY2020, Lensar's Asset Writedowns and Impairment data covers 5 years.

  • Asset Writedowns and Impairment carries a four-year compound annual growth rate of 364.6% (FY2020 to FY2024).
  • The FY2024 figure represents the highest annual Asset Writedowns and Impairment in data going back to FY2020.
  • Per Business Quant, earlier years put Asset Writedowns and Impairment at $66,000 in FY2023 (+32.0%), $50,000 in FY2022 (-81.1%), $264,000 in FY2021 and $8,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Lensar 82.90 Mn 34.78 Mn 9.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3.73 Mn
Dec 31, 2021 -43,000.00
Sep 30, 2021 303,000.00
Mar 31, 2021 4,000.00
API Access

Lensar Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=LNSR&period=max&api_key=YOUR_API_KEY